Andrieu C - Search Results

1

Computer assisted image analysis of bladder tumour nuclei for morphonuclear and ploidy assessment.

Colombel MC, Pous MF, Abbou CC, Vanvelthoven R, Bellot J, Spyratos F, Andrieu C, de Launoit Y, Chopin DK. Colombel MC, et al. Among authors: andrieu c. Anal Cell Pathol. 1994 Feb;6(2):137-47. Anal Cell Pathol. 1994. PMID: 8167096

2

Sequential cytopunctures during preoperative chemotherapy for primary breast carcinoma. II. DNA flow cytometry changes during chemotherapy, tumor regression, and short-term follow-up.

Spyratos F, Briffod M, Tubiana-Hulin M, Andrieu C, Mayras C, Pallud C, Lasry S, Rouëssé J. Spyratos F, et al. Among authors: andrieu c. Cancer. 1992 Jan 15;69(2):470-5. doi: 10.1002/1097-0142(19920115)69:2<470::aid-cncr2820690233>3.0.co;2-l. Cancer. 1992. PMID: 1728376

3

Cytokeratin analysis of breast and leukemia tumor cell lines by flow cytometry.

Ferrero M, Spyratos F, Desplaces A, Andrieu C, Phillips E, Rouëssé J. Ferrero M, et al. Among authors: andrieu c. Biol Cell. 1989;65(3):305-8. Biol Cell. 1989. PMID: 2473821

4

Multiparametric prognostic evaluation of biological factors in primary breast cancer.

Spyratos F, Martin PM, Hacène K, Romain S, Andrieu C, Ferrero-Poüs M, Deytieux S, Le Doussal V, Tubiana-Hulin M, Brunet M. Spyratos F, et al. Among authors: andrieu c. J Natl Cancer Inst. 1992 Aug 19;84(16):1266-72. doi: 10.1093/jnci/84.16.1266. J Natl Cancer Inst. 1992. PMID: 1640487

5

pS2 and response to adjuvant hormone therapy in primary breast cancer.

Spyratos F, Andrieu C, Hacène K, Chambon P, Rio MC. Spyratos F, et al. Among authors: andrieu c. Br J Cancer. 1994 Feb;69(2):394-7. doi: 10.1038/bjc.1994.73. Br J Cancer. 1994. PMID: 8297741 Free PMC article.

6

CCND1 mRNA overexpression is highly related to estrogen receptor positivity but not to proliferative markers in primary breast cancer.

Spyratos F, Andrieu C, Vidaud D, Briffod M, Vidaud M, Lidereau R, Bièche I. Spyratos F, et al. Among authors: andrieu c. Int J Biol Markers. 2000 Jul-Sep;15(3):210-4. Int J Biol Markers. 2000. PMID: 11012095

7

Epidermal growth factor receptors and prognosis in primary breast cancer.

Spyratos F, Delarue JC, Andrieu C, Lidereau R, Champème MH, Hacène K, Brunet M. Spyratos F, et al. Among authors: andrieu c. Breast Cancer Res Treat. 1990 Dec;17(2):83-9. doi: 10.1007/BF01806288. Breast Cancer Res Treat. 1990. PMID: 2096996

8

Prognostic value of a solubilized fraction of EGF receptors in primary breast cancer using an immunoenzymatic assay--a retrospective study.

Spyratos F, Martin PM, Hacène K, Andrieu C, Romain S, Floiras JL, Magdelénat H. Spyratos F, et al. Among authors: andrieu c. Breast Cancer Res Treat. 1994 Jan;29(1):85-95. doi: 10.1007/BF00666184. Breast Cancer Res Treat. 1994. PMID: 8018965 Clinical Trial.

9

Influence of the extraction procedure on plasminogen activator inhibitor-2 (PAI-2) and urokinase receptor (uPAR) assays in breast cancer tissues.

Bouchet-Bernet C, Spyratos F, Andrieu C, Deytieux S, Bécette V, Oglobine J. Bouchet-Bernet C, et al. Among authors: andrieu c. Breast Cancer Res Treat. 1996;41(2):141-6. doi: 10.1007/BF01807159. Breast Cancer Res Treat. 1996. PMID: 8944332

10

Enzyme-linked immunosorbent assay of pS2 in breast cancers, benign tumors, and normal breast tissues. Correlation with prognosis and adjuvant hormone therapy.

Predine J, Spyratos F, Prud'homme JF, Andrieu C, Hacene K, Brunet M, Pallud C, Milgrom E. Predine J, et al. Among authors: andrieu c. Cancer. 1992 Apr 15;69(8):2116-23. doi: 10.1002/1097-0142(19920415)69:8<2116::aid-cncr2820690818>3.0.co;2-b. Cancer. 1992. PMID: 1544118

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

103 results

Search Page

Filters